Bone morphogenic protein-2 use in revision total hip arthroplasty with acetabular defects
- 278 Downloads
The restoration of acetabular bone stock during revision hip arthroplasty remains a challenge. There have been no clinical series reporting the efficacy of bone morphogenic protein-2 (rhBMP-2) in the revision hip setting.
We retrospectively reviewed the radiographs and records of 15 patients who received rhBMP-2 mixed with allograft bone chips (+BMP), and 14 who received allograft bone chips alone (−BMP) for their acetabular defect during revision total hip arthroplasty with a mean two-year follow up. Radiographs were evaluated for acetabular defect size, superior cup migration, and changes in the lateral cup abduction angle. Modified Harris hip scores were used for evaluation of clinical outcomes.
Patients in the +BMP group compared to the –BMP group had significantly larger amounts of cancellous bone chips used (72.1 ± 35.5 cc vs. 38.6 ± 14.1 cc; p = 0.003). Mean rhBMP-2 used per case was 7.4 ± 3.1 mg in the +BMP group. Three patients in the –BMP group had cup migration which was not observed in the +BMP group. Mean Harris hip scores (HHS) improved post-operatively in both groups (40.1 ± 20.9 to 71.9 ± 19, p < .0001). No local adverse reaction was noted in the +BMP group.
rhBMP-2 had modest clinical benefit in the setting of revision THA. Cost of this synthetic biologic versus the added clinical benefit should be carefully considered when being used in the revision hip setting.
KeywordsRevision total hip Arthroplasty Bone morphogenic protein Bone graft Acetabular defects
Compliance with ethical standards
Conflict of interest
No funding or company participation was received for this work. None of the authors have a conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 8.Gamradt SC, Lieberman JR (2003) Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res:183–194. https://doi.org/10.1097/01.blo.0000096814.78689.77
- 12.Pountos I, Georgouli T, Henshaw K, Bird H, Jones E, Giannoudis PV (2010) The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone. J Orthop Trauma 24:552–556. https://doi.org/10.1097/BOT.0b013e3181efa8fe CrossRefPubMedGoogle Scholar
- 14.Seeherman H, Li R, Bouxsein M, Kim H, Li XJ, Smith-Adaline EA, Aiolova M, Wozney JM (2006) rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am 88:144–160. https://doi.org/10.2106/JBJS.D.02453 PubMedGoogle Scholar
- 15.Aro HT, Govender S, Patel AD, Hernigou P, Perera de Gregorio A, Popescu GI, Golden JD, Christensen J, Valentin A (2011) Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am 93:801–808. https://doi.org/10.2106/JBJS.I.01763 CrossRefPubMedGoogle Scholar
- 16.Karrholm J, Hourigan P, Timperley J, Razaznejad R (2006) Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases. Acta Orthop 77:39–48. https://doi.org/10.1080/17453670610045687 CrossRefPubMedGoogle Scholar
- 21.DeLee JG, Charnley J (1976) Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res 20–32Google Scholar
- 26.Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Li W, Chiang M, Chung J, Kwak J, Wu BM, Ting K, Soo C (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng A 17:1389–1399. https://doi.org/10.1089/ten.TEA.2010.0555 CrossRefGoogle Scholar
- 28.Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 110–120Google Scholar